Willingdon Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Willingdon Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$581K	Sell	10,429 -337	-3%	-$20.6K	0.15%	87
2019 Q4	$691K	Sell	10,766 -1,164	-10%	-$66.7K	0.14%	98
2019 Q3	$605K	Buy	11,930 +36	+0.3%	+$1.69K	0.13%	99
2019 Q2	$539K	Sell	11,894 -2,050	-15%	-$95.5K	0.13%	102
2019 Q1	$665K	Sell	13,944 -78,332	-85%	-$3.9M	0.16%	106
2018 Q4	$4.8M	Sell	92,276 -925	-1%	-$49.7K	1.38%	14
2018 Q3	$5.79M	Buy	93,201 +3,674	+4%	+$218K	1.58%	12
2018 Q2	$4.95M	Buy	89,527 +3,977	+5%	+$215K	1.52%	14
2018 Q1	$5.41M	Buy	85,550 +15,182	+22%	+$977K	1.71%	9
2017 Q4	$4.31M	Buy	70,368 +4,075	+6%	+$255K	1.42%	15
2017 Q3	$4.23M	Buy	66,293 +777	+1%	+$45.4K	1.54%	17
2017 Q2	$3.65M	Sell	65,516 -56,102	-46%	-$3.05M	1.45%	14
2017 Q1	$6.61M	Buy	121,618 +55,420	+84%	+$3.04M	2.68%	5
2016 Q4	$3.87M	Sell	66,198 -1,966	-3%	-$107K	1.83%	13
2016 Q3	$3.67M	Buy	68,164 +17,063	+33%	+$1.1M	1.86%	9
2016 Q2	$3.76M	Sell	51,101 -26,564	-34%	-$1.88M	1.93%	7
2016 Q1	$4.96M	Buy	77,665 +48,701	+168%	+$3.07M	3.04%	2
2015 Q4	$1.99M	Buy	28,964 +20,264	+233%	+$1.34M	1.82%	14
2015 Q3	$515K	Buy	+8,700	New	+$552K	0.61%	59

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Willingdon Wealth Management's BMY Position: Q1 2020 in Review

Willingdon Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 3.1% in Q1 2020, selling an estimated $20.6K and leaving 10,429 shares worth $581K. The position accounts for 0.15% of the portfolio, ranked #87.

Willingdon Wealth Management first reported a position in BMY in Q3 2015 and has held it in 19 quarters since. The position peaked at $6.61M in Q1 2017. 2,148 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

Willingdon Wealth Management held 10,429 shares of Bristol-Myers Squibb worth $581K as of Q1 2020.
Willingdon Wealth Management sold 337 Bristol-Myers Squibb shares in Q1 2020, an estimated $20.6K.
Bristol-Myers Squibb made up 0.15% of Willingdon Wealth Management's portfolio in Q1 2020, its #87 holding.
Willingdon Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2015 and has held it in 19 quarters since.
Willingdon Wealth Management's Bristol-Myers Squibb position peaked at $6.61M in Q1 2017.
2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Willingdon Wealth Management's 13F filing for Q1 2020, filed 21 Apr 2020.